- Poster Presentation
Potential role of cyclin D1in DNA damage response
Breast Cancer Research volume 8, Article number: P13 (2006)
In mammalian cells, cell cycle progression is governed by distinct cyclin-dependent kinases (cdks) whose activities are regulated by binding of their activating cyclin subunits and through negative regulation by inhibitor proteins such as p21. Cyclin levels oscillate in a phase-dependent manner, ensuring the stage-specific activation of cyclin/cdk complexes. The D-type cyclin levels are thought to act as sensors of the cellular environment: under conditions permissive for proliferation, D-type cyclins accumulate and facilitate the G1 phase progression; whereas under restrictive conditions, D-type cyclin transcription is attenuated and the protein is destabilised via ubiquitin-mediated proteolysis. In addition to the normal cell cycle regulation, a member of D-type cyclins, cyclin D1, has been implicated in the DNA damage response. Once activated, DNA damage responses disrupt the function of the cell cycle and can result in a number of outcomes including short-term or long-term cell cycle arrest, apoptosis and necrosis. Cyclin D1 expression is often found deregulated in cancerous cells, particularly in those of the breast and the head/neck.
Preliminary data showed that the expression of cyclin D1 responds to the DNA damage induced by an environmental carcinogen, 4-nitroquinoline 1-oxide (4NQO), in a biphasic manner. At a low level (2.5 μM), the cyclin D1 level is unchanged but p21 is induced strongly after 3 hours; at intermediate levels (10–50 μM), there is a dramatic reduction in the level of cyclin D1 while p21 fails to accumulate; at high levels (100–200 μM), little change in cyclin D1 or p21 is observed. The cellular responses associated with different 4NQO doses analysed by flow cytometry will be presented.
Our findings suggest that the level of cyclin D1 following the DNA damage induced by 4NQO may play a role in dictating the outcome of the cellular response. Our ongoing research aims to compare and contrast the cellular responses linked to various specific DNA damaging agents in terms of cell cycle regulatory proteins, focusing on cyclin D1, and ultimately to understand the molecular mechanisms underlying the regulation of such responses.
Linda Jacobs Breast Cancer Campaign PhD Studentship and Overseas Research Students Award.
About this article
Cite this article
Suwaki, N., Mann, D. Potential role of cyclin D1in DNA damage response. Breast Cancer Res 8 (Suppl 2), P13 (2006). https://doi.org/10.1186/bcr1568